Sulfamethoxazole and Trimethoprim Tablets, USP, 800mg/160mg Double Strength, 500 Tablets, Rx Onl...
FDA Drug Recall #D-0719-2021 — Class II — July 7, 2021
Recall Summary
| Recall Number | D-0719-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | July 7, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Aurobindo Pharma USA Inc. |
| Location | East Windsor, NJ |
| Product Type | Drugs |
| Quantity | 3800 bottles |
Product Description
Sulfamethoxazole and Trimethoprim Tablets, USP, 800mg/160mg Double Strength, 500 Tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-HIghtstown Road, EAs Windsor, NJ 08520, Made in India, NDC 65862-420-05
Reason for Recall
Presence of Foreign Substance- Potential of metal contamination.
Distribution Pattern
Nationwide
Lot / Code Information
Batch SP1D19082AA3 & Batch SP1D19085AA3; Exp 08/2022
Other Recalls from Aurobindo Pharma USA Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0492-2024 | Class II | Clorazepate Dipotassium Tablets, USP, 7.5 mg, a... | Apr 24, 2024 |
| D-0491-2024 | Class II | Clorazepate Dipotassium Tablets, USP, 3.75 mg, ... | Apr 24, 2024 |
| D-1171-2023 | Class II | Rasagiline Tablets 0.5mg, 30-count bottle, Rx o... | Aug 2, 2023 |
| D-1087-2023 | Class II | Rufinamide Tablets, USP 200 mg, packaged in 120... | Jul 21, 2023 |
| D-1088-2023 | Class II | Rufinamide Tablets, USP 400 mg, packaged in 120... | Jul 21, 2023 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.